CD154 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD154 monoclonal antibodies for research focused on understanding CD154's role in immune responses. CD154 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD154, also known as CD40 ligand, plays a critical role in the activation of T cells and regulation of immune responses. The interaction between T cells and B cells is mediated by CD154, which facilitates antibody production and promotes memory B cell development. Understanding CD154 function is essential for discovering mechanisms of immune regulation and potential therapeutic targets in autoimmune diseases and cancer. CD154 monoclonal antibodies enable precise detection and characterization of CD154 expression patterns in various cellular environments. Researchers can utilize CD154 monoclonal antibodies to investigate signaling pathways and molecular mechanisms involved in immune system regulation. CD154 monoclonal antibodies support detailed analysis of protein-protein interactions and cellular localization studies. Santa Cruz Biotechnology monoclonal antibodies for CD154 research contribute to advancing scientific understanding of immune system function and potential therapeutic applications.